These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


219 related items for PubMed ID: 15070599

  • 1. Peritonectomy and intraperitoneal hyperthermic perfusion (IPHP): a strategy that has confirmed its efficacy in patients with pseudomyxoma peritonei.
    Deraco M, Baratti D, Inglese MG, Allaria B, Andreola S, Gavazzi C, Kusamura S.
    Ann Surg Oncol; 2004 Apr; 11(4):393-8. PubMed ID: 15070599
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Feasibility of peritonectomy associated with intraperitoneal hyperthermic perfusion in patients with Pseudomyxoma peritonei.
    Deraco M, Gronchi A, Mazzaferro V, Inglese MG, Pennacchioli E, Kusamura S, Rizzi M, Anselmi RA, Vaglini M.
    Tumori; 2002 Apr; 88(5):370-5. PubMed ID: 12487553
    [Abstract] [Full Text] [Related]

  • 4. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M, Cioppa T, DE Marco G, Bing C, D'Amico S, D'Alessandro M, Fiorentini G, DE Simone M.
    In Vivo; 2009 Apr; 23(4):639-44. PubMed ID: 19567401
    [Abstract] [Full Text] [Related]

  • 5. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with peritoneal mesothelioma.
    Deraco M, De Simone M, Rossi CR, Cavaliere F, Difilippo F, Scuderi S, Pilatti P, Kusamura S.
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):41-5. PubMed ID: 16767905
    [Abstract] [Full Text] [Related]

  • 6. Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D, Kusamura S, Nonaka D, Langer M, Andreola S, Favaro M, Gavazzi C, Laterza B, Deraco M.
    Ann Surg Oncol; 2008 Feb; 15(2):526-34. PubMed ID: 18043976
    [Abstract] [Full Text] [Related]

  • 7. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S, Younan R, Baratti D, Costanzo P, Favaro M, Gavazzi C, Deraco M.
    Cancer; 2006 Mar 01; 106(5):1144-53. PubMed ID: 16456817
    [Abstract] [Full Text] [Related]

  • 8. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
    Baratti D, Kusamura S, Nonaka D, Cabras AD, Laterza B, Deraco M.
    Ann Surg; 2009 Feb 01; 249(2):243-9. PubMed ID: 19212177
    [Abstract] [Full Text] [Related]

  • 9. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA.
    Ann Surg; 2007 Jan 01; 245(1):104-9. PubMed ID: 17197972
    [Abstract] [Full Text] [Related]

  • 10. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution.
    Chua TC, Yan TD, Smigielski ME, Zhu KJ, Ng KM, Zhao J, Morris DL.
    Ann Surg Oncol; 2009 Jul 01; 16(7):1903-11. PubMed ID: 19387742
    [Abstract] [Full Text] [Related]

  • 11. Progression of pseudomyxoma peritonei after combined modality treatment: management and outcome.
    Smeenk RM, Verwaal VJ, Antonini N, Zoetmulder FA.
    Ann Surg Oncol; 2007 Feb 01; 14(2):493-9. PubMed ID: 17103067
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
    Minicozzi A, Borzellino G, Momo EN, Segattini C, Pitoni F, Steccanella F, De Manzoni G.
    Ann Ital Chir; 2008 Feb 01; 79(4):231-9. PubMed ID: 19093624
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Baratti D, Kusamura S, Martinetti A, Seregni E, Laterza B, Oliva DG, Deraco M.
    Ann Surg Oncol; 2007 Aug 01; 14(8):2300-8. PubMed ID: 17510772
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cytoreductive surgery followed by intra peritoneal hyperthermic perfusion in the treatment of peritoneal surface malignancies: morbidity and mortality with closed abdomen technique.
    Kusamura S, Deraco M, Baratti D, Inglese MG, Costanzo P, Favaro M, Manzi R, Gavazzi C.
    J Exp Clin Cancer Res; 2003 Dec 01; 22(4 Suppl):207-12. PubMed ID: 16767933
    [Abstract] [Full Text] [Related]

  • 16. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours.
    Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ.
    Eur J Surg Oncol; 2015 Mar 01; 41(3):396-9. PubMed ID: 25216980
    [Abstract] [Full Text] [Related]

  • 17. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study.
    Loungnarath R, Causeret S, Bossard N, Faheez M, Sayag-Beaujard AC, Brigand C, Gilly F, Glehen O.
    Dis Colon Rectum; 2005 Jul 01; 48(7):1372-9. PubMed ID: 15909071
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M, Casali P, Inglese MG, Baratti D, Pennacchioli E, Bertulli R, Kusamura S.
    J Surg Oncol; 2003 Jul 01; 83(3):147-53. PubMed ID: 12827682
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.